CANNBIOREX PHARMA LIMITED
Overview
| Company Name | CANNBIOREX PHARMA LIMITED |
|---|---|
| Company Status | Active |
| Legal Form | Private limited company |
| Company Number | 11331809 |
| Jurisdiction | England/Wales |
| Date of Creation |
Summary
| Has Super Secure PSCs | No |
|---|---|
| Has Charges | No |
| Has Insolvency History | No |
| Registered Office is in Dispute | No |
What is the purpose of CANNBIOREX PHARMA LIMITED?
- Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities
Where is CANNBIOREX PHARMA LIMITED located?
| Registered Office Address | 71-75 Shelton Street Covent Garden WC2H 9JQ London United Kingdom |
|---|---|
| Undeliverable Registered Office Address | No |
What are the latest accounts for CANNBIOREX PHARMA LIMITED?
| Overdue | No |
|---|---|
| Next Accounts | |
| Next Accounts Period End On | Dec 31, 2025 |
| Next Accounts Due On | Sep 30, 2026 |
| Last Accounts | |
| Last Accounts Made Up To | Dec 31, 2024 |
What is the status of the latest confirmation statement for CANNBIOREX PHARMA LIMITED?
| Last Confirmation Statement Made Up To | Apr 25, 2026 |
|---|---|
| Next Confirmation Statement Due | May 09, 2026 |
| Last Confirmation Statement | |
| Next Confirmation Statement Made Up To | Apr 25, 2025 |
| Overdue | No |
What are the latest filings for CANNBIOREX PHARMA LIMITED?
| Date | Description | Document | Type | |
|---|---|---|---|---|
Appointment of Mr Gian Singh Gill as a director on Jun 05, 2025 | 2 pages | AP01 | ||
Total exemption full accounts made up to Dec 31, 2024 | 8 pages | AA | ||
Confirmation statement made on Apr 25, 2025 with no updates | 3 pages | CS01 | ||
Termination of appointment of Marc Feldmann as a director on Sep 16, 2024 | 1 pages | TM01 | ||
Appointment of Mr Lloyd Blair as a director on Sep 16, 2024 | 2 pages | AP01 | ||
Confirmation statement made on Apr 25, 2024 with no updates | 3 pages | CS01 | ||
Unaudited abridged accounts made up to Dec 31, 2023 | 8 pages | AA | ||
Director's details changed for Sir Marc Feldmann on Feb 23, 2024 | 2 pages | CH01 | ||
Registered office address changed from 601 International House 223 Regent Street London W1B 2QD England to 71-75 Shelton Street Covent Garden London WC2H 9JQ on Feb 23, 2024 | 1 pages | AD01 | ||
Confirmation statement made on Apr 25, 2023 with no updates | 3 pages | CS01 | ||
Unaudited abridged accounts made up to Dec 31, 2022 | 8 pages | AA | ||
Confirmation statement made on Apr 25, 2022 with no updates | 3 pages | CS01 | ||
Total exemption full accounts made up to Dec 31, 2021 | 7 pages | AA | ||
Total exemption full accounts made up to Dec 31, 2020 | 7 pages | AA | ||
Confirmation statement made on Apr 25, 2021 with updates | 4 pages | CS01 | ||
Registered office address changed from Suite 303 116 Baker Street London W1U 6TS United Kingdom to 601 International House 223 Regent Street London W1B 2QD on Feb 16, 2021 | 1 pages | AD01 | ||
Termination of appointment of Lawrence Pemble as a director on Feb 16, 2021 | 1 pages | TM01 | ||
Confirmation statement made on Apr 25, 2020 with updates | 4 pages | CS01 | ||
Total exemption full accounts made up to Dec 31, 2019 | 7 pages | AA | ||
Registered office address changed from 601 International House 223 Regent Street London W1B 2QD England to Suite 303 116 Baker Street London W1U 6TS on Feb 24, 2020 | 1 pages | AD01 | ||
Total exemption full accounts made up to Dec 31, 2018 | 7 pages | AA | ||
Current accounting period shortened from Apr 30, 2019 to Dec 31, 2018 | 1 pages | AA01 | ||
Registered office address changed from North West House 119 Marylebone Road London NW1 5PU England to 601 International House 223 Regent Street London W1B 2QD on Dec 17, 2019 | 1 pages | AD01 | ||
Confirmation statement made on Apr 25, 2019 with updates | 5 pages | CS01 | ||
Registered office address changed from 601 International House 223 Regent Street London W1B 2QD United Kingdom to North West House 119 Marylebone Road London NW1 5PU on Apr 05, 2019 | 1 pages | AD01 | ||
Who are the officers of CANNBIOREX PHARMA LIMITED?
| Name | Appointed On | Resigned On | Role | Address | Company Identification | Country of Residence | Nationality | Date of Birth | Occupation | Number |
|---|---|---|---|---|---|---|---|---|---|---|
| BLAIR, Lloyd | Director | Shelton Street Covent Garden WC2H 9JQ London 71-75 United Kingdom | Canada | Canadian | Financial Consultant | 327180840001 | ||||
| GILL, Gian Singh | Director | Shelton Street Covent Garden WC2H 9JQ London 71-75 United Kingdom | England | British | Director | 180737380001 | ||||
| FELDMANN, Marc, Sir | Director | Shelton Street Covent Garden WC2H 9JQ London 71-75 United Kingdom | England | British | Chairman And Ceo | 174942280001 | ||||
| PEMBLE, Lawrence | Director | 223 Regent Street W1B 2QD London 601 International House United Kingdom | England | British | Director And Coo | 245760040001 |
Who are the persons with significant control of CANNBIOREX PHARMA LIMITED?
| Name | Notified On | Address | Ceased | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cannbiorex Pharmaceuticals Corp | May 04, 2018 | Suite 1305 BCV6E3V7 Vancouver 1090 W Georgia Street Canada | No | ||||||||||
| |||||||||||||
Natures of Control
| |||||||||||||
| Mr Lawrence Pemble | Apr 26, 2018 | 223 Regent Street W1B 2QD London 601 International House United Kingdom | Yes | ||||||||||
Nationality: British Country of Residence: England | |||||||||||||
Natures of Control
| |||||||||||||
Data Source
- UK Companies House
The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings. - license: CC0